The RPCI Biopolymer Resource is a biomolecular core Resource that provides advice and technical services to the staff in the design, synthesis, and characterization of oligonucleotides and peptides; automated DNA sequencing; and the isolation, purification and characterization of proteins. The Resource emphasizes support to staff in developing and understanding the uses and applications of the various techniques and provides convenient access to the technical services. In order to accommodate the evolving research needs and interests of RPCI staff and to support the technical r requirements of the various projects, the Resource has recently added new areas of emphasis and expertise. These include fluorescence-based, """"""""real time"""""""" PCR for quantifying gene expression; mass spectrometry for the characterization (and identification) of proteins and peptides and generical applicability to proteomics; and the synthesis of """"""""specialty"""""""" oligonucleotides such as the dual-labeled probes. for fluorogenic N5'-nuclease assays. The DNA sequencing capability of the Resource has also been recently upgraded to higher sensitivity and throughput, and is now capable of sequencing BAC and PAC clones. The Resource continues to be a heavily used core resource-in 1998, technical services were provided to over 50 senior RPCI staff, supported over 80 publications, and there was an approximately 50% increased in the services provided in the areas of oligonucleotide synthesis, DNA sequencing, mas spectroscopy and chromatography. The new technical services offered by the Resource have increased and diversified its user base, and as these techniques become fully implemented, use of the Resource is expected to further increase.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-26
Application #
6452243
Study Section
Project Start
2001-05-07
Project End
2003-04-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380
Eng, Kevin H; Szender, J Brian; Etter, John Lewis et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14:e1007194
Tubbs, Anthony; Sridharan, Sriram; van Wietmarschen, Niek et al. (2018) Dual Roles of Poly(dA:dT) Tracts in Replication Initiation and Fork Collapse. Cell 174:1127-1142.e19
Bucsek, Mark J; Giridharan, Thejaswini; MacDonald, Cameron R et al. (2018) An overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunity. Int J Hyperthermia 34:135-143
Leonova, Katerina; Safina, Alfiya; Nesher, Elimelech et al. (2018) TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells. Elife 7:
Verma, Aparajita; Rich, Laurie J; Vincent-Chong, Vui King et al. (2018) Visualizing the effects of metformin on tumor growth, vascularity, and metabolism in head and neck cancer. J Oral Pathol Med 47:484-491
Sheffer, Christine E; Miller, Austin; Bickel, Warren K et al. (2018) The treasure of now and an uncertain future: Delay discounting and health behaviors among cancer survivors. Cancer 124:4711-4719
Nesher, Elimelech; Safina, Alfiya; Aljahdali, Ieman et al. (2018) Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs. Cancer Res 78:1431-1443
Azad, T; Janse van Rensburg, H J; Lightbody, E D et al. (2018) A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nat Commun 9:1061

Showing the most recent 10 out of 1555 publications